Skip to content

ONCO SENGY

Active
Private limited companyfounded 2025active for 1 yearClos de l' Aronelle 21, 1474 Genappe, BelgiumKBO/BCE: BE 1025.592.282
Summary

ONCO SENGY has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,749 and a net result of €56,749. Its solvency ranks better than 48% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €180,000turnover 2025, estimated
Equity
€60,749
Profit
€56,749
Turnover estimated from the gross margin
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 15 days early
Why 97lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.01, cash €50,672Equity €60,749 (61.2% of total assets)Figures for financial year 2025 (filed 16-07-2026)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 75% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 86
equity 61.2% of total assets
Liquidity 100
short-term debt 9.0% · cash 51.1%
Profitability 100
return on assets 57.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 08-2026: < 0.1%lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity ample (current ratio 6.01, above the usual 1.5; short-term debt: 9% and cash: 51.1% of total assets), and 38.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 49% on solvency, 95% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.01, cash €50,672
NBB · annual accounts
lowers risk · Equity €60,749 (61.2% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 16-07-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
15 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: TEMIAN VICOL Daiana Cosmina…

Key points

  • Founded 15 months agofounded 16-07-2025 15 months View
  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €99,183 View

By topic

Financials

Financial year
2025
Total assets
€99,183
Profit
€56,749
Solvency
61.2%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
16-07-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
32
Annual meeting
Third Friday of June at 18:00
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about ONCO SENGY

What is the company number of ONCO SENGY?
1025.592.282. In Belgium the VAT number is the company number with BE in front: BE 1025.592.282.
Where is ONCO SENGY based?
The registered office is at Clos de l' Aronelle 21, 1474 Genappe.Company details
What does ONCO SENGY do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ONCO SENGY?
Private limited company (BV).
When was ONCO SENGY founded?
On 16-07-2025.
Is ONCO SENGY still active?
Yes, ONCO SENGY is an active enterprise in the KBO register.
What is the turnover of ONCO SENGY?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is ONCO SENGY profitable?
In financial year 2025, ONCO SENGY made a profit of €56,749.
Where can I find the annual accounts of ONCO SENGY?
ONCO SENGY filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to ONCO SENGY

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.